
25.5K
ANWho’s here for reducing your IBS symptoms this IBS Awareness Month? #biogaiapartner
I’ve partnered with @biogaia.ca to talk about something that actually matters when you’re living with IBS - managing those debilitating symptoms!
I know for me, and my patients - a bad IBS day means impacts to not just how you feel, but how you are able to function!
So how do we increase those better days?
There are evidence-based tools that can help:
✔️ Targeted dietary strategies (like the low FODMAP diet)
✔️ Gut-directed hypnotherapy
✔️ Strain-specific probiotics
BioGaia Gastrus contains two clinically studied strains of Limosilactobacillus reuteri that have been shown to(1,2):
- reduce the frequency and severity of symptoms associated with IBS, like abdominal pain, gas, and bloating
- Help promote bowel movements & regularity in functional constipation (hello! IBS-C girly here!)
- Helps support intestinal/gastrointestinal health
The combination of L. reuteri strains have also shown to improve overall quality of life in both adults and children—including up to 76% more pain-free days(2).
Who’s all for more good days this IBS Awareness Month? Share below the 1 thing you’re working on this month to improve your digestive symptoms!
#biogaiacanada #IBSawarenessmonth
References:
1. Cruchet, S., Hirsch, S., Villa-López, D., Moreno-Portillo, M., Palomo, J. C., Abreu-Abreu, A. T., ... & Gutiérrez-Castrellón, P. (2024). Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial. Frontiers in Gastroenterology, 2, 1296048.
2. Jadrešin, O., Hojsak, I., Mišak, Z., Kekez, A. J., Trbojević, T., Ivković, L., & Kolaček, S. (2017). Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study. Journal of pediatric gastroenterology and nutrition, 64(6), 925-929.
@andreahardyrd










